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Summary.-An electrolytic reduction system has been developed to model the
cytotoxic action of a range of nitroimidazole drugs against DNA in hypoxic cells or
anaerobic microorganisms. The degreeof damage induced bythesedrugs (measured
as the release of [14C]-dT from DNA) and their relative rates of reduction have been
correlated with their redox potentials. The results show that the correlation of drug-
induced damage and electron affinity is related to the amount of drug reduced, and
supports the hypothesis that at the molecular level the cytotoxic mechanism of re-
duced nitroimidazoles is identical inhypoxic mammalian cells, bacteria and protozoa.
HYPoxic CELLS are more resistant to
ionizing radiation than well oxygenated
ones, and their presence in human
tumours may lead to the failure of radio-
therapy. In addition to their ability as
radiosensitizers, nitroimidazoles are select-
ively cytotoxic to hypoxic cells (Adams et
al., 1978). The basis of structure-activity
relationships in the development of elec-
tron-affinic nitroheterocyclic hypoxic cell
radiosensitizers is a linear correlation of
the type:
-log C=bo+biE +b2logP+b3 (logP)2
where C is the drug concentration re-
quired to cause a specific and relevant
biological effect, E is the electron affinity,
usually expressed as the one-electron
redox potential (E71), and P is the lipid-
water partition coefficient of the drug.
Adams et al. (1979a,b) have shown that
lipophilicity has a negligible effect on
radiosensitizing efficiency and cyto-
toxicity. Thus coefficients b2 and b3 may
be omitted, yielding the simplified equa-
tion
-log C=bo+blE
It is well-established that the E71 value
correlates positively with radiosensitiza-
tion efficiency (Adams et al., 1976, 1979a),
aerobic cytotoxicity (Adams et al., 1979b),
mutagenicity (Chin et al., 1978) and
hypoxic cytotoxicity (Adams et al., 1980).
The more electron-affinic the drug (the
more positive the E71 value) the greater
the radiosensitization and cytotoxicity,
which varies in general by an order of
magnitude for each 100mV change in E71.
These correlations suggest that redox
processes are involved both in radiosensi-
tization and cytotoxicity, but do not indi-
cate a common mechanism, since radio-
sensitization is a fast process occurring in
a few milliseconds (Adams et al., 1975) and
is temperature-independent, whereas cyto-
toxicity is relatively slow and is tempera-
ture-dependent (Stratford & Adams, 1977;
Hall et al., 1977). These criteria of nitro-
imidazole cytotoxicity to mammalian cells
also apply to their effect on anaerobic
microorganisms. However, the correlation
of cytotoxicity and electron affinity is, in
this case, a negative one: that is, the less
electron-affinic the drug the greater its
cytotoxicity, which generally doubles for
each 1OOmV decrease in E71 (Reynolds,
1980, 1981). The evidence that toxicities
to hypoxic mammalian cells and to
anaerobic microorganisms depend uponR. J. KNOX, R. C. KNIGHT AND D. J. EDWARDS
the reduction of the nitro group (Edwards
et al., 1973; Flockhart et al., 1978) suggests
a common mechanism.
To clarify the interaction of reduced
nitroimidazoles with their target, we have
developed an electrochemical model in
which the nitro group of the drug may be
selectively reduced at a controlled poten-
tial in the presence of DNA, and damage
to the latter subsequently analysed
(Knight et al., 1978, 1979; Rowley et al.,
1979; Edwards et al., 1980a,b). It has been
established recently that reduced nitro-
imidazole-induced damage to DNA is
related to its base composition (Rowley
et al., 1980) and is associated specifically
with the release of thymidine phosphates
from DNA (Knox et al., 1980, 1981;
Edwards et al., 1980b). We report the use
of such an in vitro model system to in-
vestigate structure-activity correlations
of the reduced nitroimidazole drug-target
interaction.
MATERIALS AND METHODS
DNA type VIII from Escherichia coli B was
obtained from the Sigma Chemical Co. Ltd,
Dorset, and [14C-C2]dT-labelled E. coli DNA
from the Radiochemical Centre, Amersham,
Bucks. Misonidazole (2-nitro-1-imidazolyl-3-
methoxy-2-propanol), ornidazole (1-(3-chloro-
2-hydroxypropyl)-2-methyl-5-nitroimidazole)
and benznidazole (N-benzyl-1-(2-nitro-1-
imidazolyl)acetamide) were generously don-
ated by Roche Products Ltd, Welwyn Garden
City, Herts, and metronidazole (1-2'-hydroxy-
ethyl-2-methyl-5-nitroimidazole), dimetrid-
azole (1,2-dimethyl-5-nitroimidazole) and
8609 RP (1,2-dimethyl-4-nitroimidazole) were
generous gifts from May and Baker Ltd,
Dagenham, Essex. Tinidazole (ethyl-1-[2-(2-
methyl - 5 - nitroimidazolyl) - ethyl]sulphone)
was donated by Pfizer Ltd, Sandwich, Kent.
Nimorazole (4[2-(5-nitroimidazol-1-yl)ethyl]-
morpholine) from Carlo Erba Ltd, Rome,
Italy; azomycin (2-nitroimidazole) from the
Sigma Chemical Co. and 4,(5)-nitroimidazole
from the Aldrich Chemical Co., Gillingham,
Dorset.
Reduction of the nitro group of each drug
was carried out in the presence of DNA at
potentials shown in the Table, as previously
described (Knight et al., 1979). In general,
10 Ing E. coli DNA, 10 jug 14C-DNA and
20 ,umoles of drug in 67 ml 15mM NaCl,
1 5mM trisodium citrate buffer, pH 7-1 (0-1
SSC) was made anoxic by purging with N2
and reduction carried out using an Hg pool
cathode and Ag/AgCl anode at an initial
current density of 30 puA. Samples were re-
moved before and after reduction, which was
measured as the loss of absorbance at the
A max of each drug and zero current when
reduction was completed. DNA damage was
measured as the amount of [14C]-dT release
after dialysis for 18 h against water (Knox et
al., 1981). Alternatively, reduction was car-
ried out at a constant potential of -500 mV
for 24 h and DNA damage assessed as de-
scribed above. The amount of reduction was
measured spectrophotometrically as the rela-
tive decrease in the A max of each drug.
Spectrophotometry was performed with a
Pye-Unicam SP-800 Series B or SP 8150
scanning spectrophotometer, and radio-
activity measured in a liquid scintillationi
spectrometer as previously described (Knox
et al., 1981).
All polarographic half-wave potentials
(E2) were determined as previously described
(Knight etal., 1979) and El values quoted are
those relative to the standard Ag/AgCl
electrode. Values of the one-electron redox
potential (E71) are taken from published data
and are relative to the normal hydrogen
electrode.
All data points relating to log 1/C are
accurate to +5% of aniy quoted value, and
the straight-line and correlation data are
computer-derived using a least-squares pro-
gramme.
RESULTS
The Table summarizes the results from
10 nitroimidazoles reduced in the presence
ofE. coli DNA, where damage is measured
as the percentage total dT released by the
action of the reduced drug. The results
were fitted to a Hansch-type plot (Fig. 1)
which shows a linear correlation described
by the equation, and corresponds to that
obtained by Reynolds (1981)in Bacteriodes
fragilis, where cytotoxicity was assessed
by minimum inhibitory concentration.
log C=-0-003 E71 1-4 (r = 0-70)
A similar, negative, correlation is ob-
tained ifEl values are used in place ofthe
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TABLE.-Redox values of and damage produced by reduced nitroimidazoles
Reduction
potential
No.
1
2
3
4
5
6
7
8
9
10
Drug
Benznidazole
Misonidazole
Nimorazole
Ornidazole
Tinidazole
Azomycin
Metronidazole
Dimetridazole
8609 RP
4(5) Nitroimidazole
EJ
- 200
-272
- 345
- 345
-340
-374
- 382
-388
-475
-540
E71
- 380
-389
-457
-467
-464
-418
-486
-475
-550*
-527
Damage
2-7
5-0
4-05
7-4
12-7
6-0
9.5
10-4
10-3
7-5
Log '/c+
-0-569
- 0-301
-0-393
- 0-131
0-104
-0-222
- 0-022
0-017
0-013
-0-125
(mV)
- 700
-800
-850
-850
- 850
- 900
- 900
-900
- 1000
- 1000
EJ is the polarographic half-wave potential in mV measured against an Ag/AgCl reference electrode at
pH 7-0.
E71 is the one-electron redox potential in mV measured against the normal hydrogen electrode.
Damage measured as the percentage release of [14C]-dT from DNA.
t C is the calculated drug-nucleotide ratio to produce a 10% release of dT from DNA.
* The value is computer-calculated on the basis of structural similarities to other drugs (Wardman,
personal communication).
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FIG. 1.-Linear correlation between DNA
damage and electron affinity for 10 nitro-
imidazoles. (Identification in Table.) Log
1/c and E71 are defined infootnote to Table.
Log damage
n.A- _
-02-
4
300 400 500 f00
E1(mV)
FIG. 3.-Relationship between relative reduc-
tion of nitroimidazoles and their electron
2 affinity.
0 ,
\- E71 values. As partition effects play no
-0-4- \ 4 part in the electrochemical model, no attempt has been made to include them,
-0-8- 7 since they play an insignificant part in
mammalian cells (Adams et al., 1979a,b,
1980), bacteria (Reynolds, 1981) or pro- tozoa (Chien & Mizuba, 1978).
-1.f;- \ An alternative mode of electrolytic
9.\ reduction was carried out on 4 nitro-
_____________________________ .imidazoles covering the range (El) of
_300 400 500 -600 -272 to - 475 mV which were reduced at
E(mV) -500 mV for 24hi. This experiment was
FIG. 2. Relationship between DNA damage designed to model weak redox systems,
measured as the percentage dT release and which probably to those in the electron affinity of 4 nitroimidazoles. correspond
(See Table.) hypoxic cells. The results of such reduc-
1-o)
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tions when plotted graphically, show a
linear relationship between the log of
DNA damage and the electron affinity
(Fig. 2) whichis described bythe equation:
-log C=0-011 E71+4-474 (r=0.97)
This correlation is very similar to those
obtained between electron affinity and
cytotoxicity in hypoxic cells (Adams et al.,
1980; Olive, 1979b, 1980).
This latter correlation, however, arises
as a consequence of the amount of drug
reduced, as may be seen from Fig. 3,
which shows an identical correlation
between the log of drug reduction and
their electron affinity. In all the results
described it is significant that the un-
reduced drugs show none of these effects.
DISCUSSION
The results establish that the correlation
of drug-induced damage and electron
affinity is related to the amount of drug
reduced, and thus depends upon the end-
point chosen to assess the cytotoxic effect
ofany drug.
If complete drug reduction occurs, a
negative correlation is obtained (Fig. 1)
which is almost identical to that found for
anaerobic bacteria (Reynolds, 1981). How-
ever, if a unit timescale is considered, a
positive correlation is obtained, identical
to that found in hypoxic cells as indicated
by cell survival, inhibition of cell growth,
mutagenicity, inhibition of DNA syn-
thesis or production ofDNA strand breaks
(Adams et al., 1979b; Olive, 1979b, 1980).
Since the mechanism of action of cyto-
toxicity is identical in each case (viz. DNA
damage) it becomes apparent that a posi-
tive correlation arises as a result of the
different rates of reduction of the drugs,
which are themselves a direct function of
their relative electron affinity (Fig. 3). The
metabolic reduction rates of nitroimid-
azoles in hypoxic cells are well established
(Olive, 1979a, 1980) and show an identical
correlation with electron affinity to those
relative rates obtained by electrolytic
reduction at constant potential. Thus
from published data (Olive, 1979a, 1980)
the positive correlation obtained for E71
and cytotoxicity in hypoxic mammalian
cells can be corrected for relative drug-
reduction rates to produce a negative
correlation.
TheE71valueisameasureoftheelectron
affinity of the nitro group which deter-
mines radiosensitization properties (Adams
et al., 1976; 1979a). However, the anaer-
obic cytotoxicity is generally considered
to be due to a reduced species, the concen-
tration of which is governed by the rate
of its formation (i.e. reduction) which
depends upon a reduction-rate-generated
concentration gradient (Ings et al., 1974)
and its relative stability. Since the data
shown in Fig. 1 do not involve reduction
rates or concentration gradients, the
results indicate that the reduced drug
derivative is more stable at low E71 values
than at high ones, and the correlation in
Fig. 1 may well reflect the relative stabili-
ties of the cytotoxic agents. Experiments
to determine the relative stabilities of re-
duced one-electron derivatives of nitro-
imidazoles are in progress.
Although the present study is limited to
E. coli, previous studies have shown that
specific dT release occurs from DNAs of
Micrococcus lysodeikticus, E. coli, calf
thymus and Clostridium perfrinyens; i.e.
with A+T values ranging from 28% to
71%. In addition, whilst maximum re-
lease occurs from poly(d[AT]) none occurs
from poly(d[GC]) (Rowley et al., 1980;
Knox et al., 1980, 1981). This suggests that
althoughthe magnitude ofthe cytotoxicity
may vary with the DNA A+T content of
the cell, the results obtained in the present
study would be applicable to all cell types.
The results support the hypothesis that
the cytotoxic mechanism of action of
reduced nitroimidazoles is identical in
hypoxic mammalian cells, bacteria and
protozoa. Differences would arise, how-
ever, in hypoxic cells due to the weak
redox systems which predominate, result-
ing in those drugs which are cytotoxically
potent in anaerobes being relatively less
effective in hypoxic mammalian cells in
vivo.
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Although radiosensitization and cyto-
toxicity of nitroheterocyclic drugs in vivo
may both be readily predicted from their
electron affinities, these effects are, how-
ever, mechanistically distinct.
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